Katarzyna Szczepanska

Smętna 12 Str
Krakow, MA 31343, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

SERAAK2 as a Serotonin Receptor Ligand: Structural and Pharmacological In Vitro and In Vivo Evaluation.

SERAAK2 as a Serotonin Receptor Ligand: Structural and Pharmacological In Vitro and In Vivo Evaluation.

Journal: Molecules (Basel, Switzerland)
Published: October 13, 2025

Guanidine Derivative ADS1017, a Potent Histamine H3 Receptor Antagonist with Promising Analgesic Activity and Satisfactory Safety Profile.

Guanidine Derivative ADS1017, a Potent Histamine H3 Receptor Antagonist with Promising Analgesic Activity and Satisfactory Safety Profile.

Journal: ACS chemical neuroscience
Published: December 09, 2024

Histamine H3 receptor blockade alleviates neuropathic pain through the regulation of glial cells activation.

Histamine H3 receptor blockade alleviates neuropathic pain through the regulation of glial cells activation.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 18, 2024

AR71, Histamine H3 Receptor Ligand-In Vitro and In Vivo Evaluation (Anti-Inflammatory Activity, Metabolic Stability, Toxicity, and Analgesic Action).

AR71, Histamine H3 Receptor Ligand-In Vitro and In Vivo Evaluation (Anti-Inflammatory Activity, Metabolic Stability, Toxicity, and Analgesic Action).

Journal: International journal of molecular sciences
Published: June 21, 2024

The Effect of KSK-94, a Dual Histamine H3 and Sigma-2 Receptor Ligand, on Adipose Tissue in a Rat Model of Developing Obesity.

The Effect of KSK-94, a Dual Histamine H3 and Sigma-2 Receptor Ligand, on Adipose Tissue in a Rat Model of Developing Obesity.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 24, 2024

4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H3 Receptors and Cholinesterases.

4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H3 Receptors and Cholinesterases.

Journal: ACS chemical neuroscience
Published: March 05, 2024

Efficacy of the Multi-Target Compound E153 in Relieving Pain and Pruritus of Different Origins.

Efficacy of the Multi-Target Compound E153 in Relieving Pain and Pruritus of Different Origins.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 18, 2023

Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain.

Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain.

Journal: Journal of medicinal chemistry
Published: July 07, 2023

Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands.

Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands.

Journal: Pharmacological reports : PR
Published: June 16, 2023

Structure-Activity Relationship and Solubility Studies of N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists.

Structure-Activity Relationship and Solubility Studies of N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists.

Journal: ChemMedChem
Published: May 24, 2023

Evaluation of Some Safety Parameters of Dual Histamine H3 and Sigma-2 Receptor Ligands with Anti-Obesity Potential.

Evaluation of Some Safety Parameters of Dual Histamine H3 and Sigma-2 Receptor Ligands with Anti-Obesity Potential.

Journal: International journal of molecular sciences
Published: March 08, 2023

Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents - Design, synthesis, structural studies and pharmacological profiling.

Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents - Design, synthesis, structural studies and pharmacological profiling.

Journal: European journal of medicinal chemistry
Published: December 23, 2022
Showing 1-12 of 31

Last Updated: 09/26/2026